Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial.
Popolo Rubbio A, Testa L, Pivato CA, Regazzoli D, Piccolo R, Esposito G, Musto C, Scalia L, Pacchioni A, Briguori C, Lucisano L, De Luca L, Conrotto F, Tartaglia F, Latini AC, Stankowski K, Chiarito M, Sardella G, Indolfi C, Bedogni F, Reimers B, Condorelli G, Stefanini GG.
Popolo Rubbio A, et al. Among authors: testa l.
Cardiovasc Revasc Med. 2024 Apr 16:S1553-8389(24)00174-X. doi: 10.1016/j.carrev.2024.04.022. Online ahead of print.
Cardiovasc Revasc Med. 2024.
PMID: 38702260